It is obvious that the risks presented by the novel coronavirus (COVID-19) transcend “business as usual” for market participants. How should Boards be approaching the risks and opportunities presented by the situation to satisfy their “Caremark” duties and ensure the appropriate risk management processes and response plans are in place?

This communication, which we believe may be of interest to our clients and friends of the firm, is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal advice. This may be considered attorney advertising in some jurisdictions. Please refer to the firm's privacy notice for further details.